1. Home
  2. Companies
  3. Clinical Trials

Clinical Trials companies

12 companies

12 companies
Claris Ventures logoCV

Claris Ventures

Equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

Cambrian Biopharma logoCB

Cambrian Biopharma

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent i…

Aditum Bio logoAB
3 jobs

Aditum Bio

Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.

Debiopharm Innovation Fund logoDI

Debiopharm Innovation Fund

Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases.

ALIVE logoAL

ALIVE

ALIVE is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem of strategic partners comprising leading hospital chains, HMOs and financ…

InnoCom Bio Equities logoIB

InnoCom Bio Equities

We're sophisticated managers of a life sciences venture capital fund.

Cure Ventures logoCV

Cure Ventures

Identifying true innovations and building ambitious companies.

Third Rock Ventures logoTR

Third Rock Ventures

At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families.

Sound Bioventures logoSB

Sound Bioventures

We are a venture capital firm investing in about-to-be clinical and clinical stage private companies in Europe and the USA.

SymBiosis logoSY

SymBiosis

We are long-term investors in engineering biology to treat - or better, cure - human disease.

Curie.Bio logoCU

Curie.Bio

Curie.Bio is a new model for venture capital in biotech. We are focused on a singular mission – helping founders launch therapeutics companies that go on to rai…

The Dementia Discovery Fund logoTD

The Dementia Discovery Fund

A £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.